DK0484340T3 - Behandling til nedsættelse af ødem ved hjerne- og muskelbeskadigelser - Google Patents

Behandling til nedsættelse af ødem ved hjerne- og muskelbeskadigelser

Info

Publication number
DK0484340T3
DK0484340T3 DK90909011.0T DK90909011T DK0484340T3 DK 0484340 T3 DK0484340 T3 DK 0484340T3 DK 90909011 T DK90909011 T DK 90909011T DK 0484340 T3 DK0484340 T3 DK 0484340T3
Authority
DK
Denmark
Prior art keywords
brain
edema
corticotropin
musculature
injury
Prior art date
Application number
DK90909011.0T
Other languages
English (en)
Inventor
Edward T Wei
Original Assignee
Univ California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ California filed Critical Univ California
Application granted granted Critical
Publication of DK0484340T3 publication Critical patent/DK0484340T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/2228Corticotropin releasing factor [CRF] (Urotensin)
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00Preservation of bodies of humans or animals, or parts thereof
    • A01N1/02Preservation of living parts
    • A01N1/0205Chemical aspects
    • A01N1/021Preservation or perfusion media, liquids, solids or gases used in the preservation of cells, tissue, organs or bodily fluids
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00Preservation of bodies of humans or animals, or parts thereof
    • A01N1/02Preservation of living parts
    • A01N1/0205Chemical aspects
    • A01N1/021Preservation or perfusion media, liquids, solids or gases used in the preservation of cells, tissue, organs or bodily fluids
    • A01N1/0226Physiologically active agents, i.e. substances affecting physiological processes of cells and tissue to be preserved, e.g. anti-oxidants or nutrients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Dentistry (AREA)
  • Environmental Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Physiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
DK90909011.0T 1989-07-28 1990-05-30 Behandling til nedsættelse af ødem ved hjerne- og muskelbeskadigelser DK0484340T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/386,885 US5137871A (en) 1989-07-28 1989-07-28 Treatment to reduce edema for brain and musculature injuries

Publications (1)

Publication Number Publication Date
DK0484340T3 true DK0484340T3 (da) 1996-04-22

Family

ID=23527476

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90909011.0T DK0484340T3 (da) 1989-07-28 1990-05-30 Behandling til nedsættelse af ødem ved hjerne- og muskelbeskadigelser

Country Status (11)

Country Link
US (2) US5137871A (da)
EP (1) EP0484340B1 (da)
JP (1) JP3012319B2 (da)
AT (1) ATE131064T1 (da)
AU (1) AU641166B2 (da)
CA (1) CA2064039C (da)
DE (1) DE69024053T2 (da)
DK (1) DK0484340T3 (da)
ES (1) ES2081989T3 (da)
IE (1) IE63053B1 (da)
WO (1) WO1991001997A1 (da)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5137871A (en) * 1989-07-28 1992-08-11 Regents Of The University Of California Treatment to reduce edema for brain and musculature injuries
US5488033A (en) * 1989-07-28 1996-01-30 The Regents Of The University Of California Treatment to reduce edema
US5374621A (en) * 1991-09-13 1994-12-20 Regents Of The University Of California Neurotensin method for inhibiting vascular leakage
US6039956A (en) * 1994-09-12 2000-03-21 Pennsylvania, Trustees Of The University Of, The Corticotropin release inhibiting factor and methods of using same for treating behavioral symptoms in an anxiety disorder
US5830866A (en) * 1994-09-12 1998-11-03 The Trustees Of The University Of Pennsylvania Corticotropin release inhibiting factor and methods of using same
US5869450A (en) * 1996-03-06 1999-02-09 The Regents Of The University Of California Anti-inflammatory compositions and method with corticotropin-releasing factor analogs
US6011066A (en) * 1998-02-02 2000-01-04 Veterans General Hospital-Taipei Method for treating septic shock
EP1579871A1 (en) * 1998-12-22 2005-09-28 Genentech, Inc. Vascular endothelial cell growth factor antagonists and uses thereof
US6849600B2 (en) * 2002-03-25 2005-02-01 The Regents Of The University Of California, Berkeley Corticotropin-releasing hormone analogs
CA2572777A1 (en) * 2004-07-08 2006-03-02 Aimsco Limited Medicament comprising corticotropin releasing factor and proopiomelanocortin, and uses thereof
GB0415359D0 (en) * 2004-07-08 2004-08-11 Aimsco Ltd Medicament
GB0600202D0 (en) * 2006-01-06 2006-02-15 Aimsco Ltd Treatment of HIV
US7455447B2 (en) * 2006-05-19 2008-11-25 Mediatek Inc. Method and apparatus for a portable device
EP2341942A1 (en) 2008-09-19 2011-07-13 Nektar Therapeutics Polymer conjugates of therapeutic peptides
CN104602682B (zh) 2012-05-08 2018-12-14 埃罗米克斯公司 用于治疗水通道蛋白介导的疾病的化合物
US20160279155A1 (en) 2013-11-06 2016-09-29 Aeromics, Inc. Novel formulations

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3980778A (en) * 1973-10-25 1976-09-14 The Upjohn Company Anti-inflammatory steroid
US4579844A (en) * 1976-05-13 1986-04-01 Johnson & Johnson Topical anti-inflammatory drug therapy
US4404198A (en) * 1979-01-24 1983-09-13 Beecham Inc. Phenyl Salicylate as a topical anti-inflammatory
US4415558A (en) * 1981-06-08 1983-11-15 The Salk Institute For Biological Studies CRF And analogs
US4517181A (en) * 1982-09-15 1985-05-14 The Salk Institute For Biological Studies Mammalian PGRF
WO1984001378A1 (en) * 1982-09-29 1984-04-12 Karl P Lederis Urotensin peptides
US4528189A (en) * 1983-02-03 1985-07-09 The Salk Institute For Biological Studies Urotensin peptides
US4489163A (en) * 1983-04-14 1984-12-18 The Salk Institute For Biological Studies rCRF and analogs
US4594329A (en) * 1984-05-14 1986-06-10 The Salk Institute For Biological Studies CRF analogs
US4605642A (en) * 1984-02-23 1986-08-12 The Salk Institute For Biological Studies CRF antagonists
US4801612A (en) * 1986-07-03 1989-01-31 Regents Of The University Of California Method of inhibiting inflammatory response
US5137871A (en) * 1989-07-28 1992-08-11 Regents Of The University Of California Treatment to reduce edema for brain and musculature injuries

Also Published As

Publication number Publication date
EP0484340B1 (en) 1995-12-06
ATE131064T1 (de) 1995-12-15
US5306710A (en) 1994-04-26
US5137871A (en) 1992-08-11
CA2064039A1 (en) 1991-01-29
IE63053B1 (en) 1995-03-22
IE902737A1 (en) 1991-02-27
AU5749290A (en) 1991-03-11
AU641166B2 (en) 1993-09-16
CA2064039C (en) 2001-01-02
DE69024053T2 (de) 1996-07-04
ES2081989T3 (es) 1996-03-16
JP3012319B2 (ja) 2000-02-21
JPH05501856A (ja) 1993-04-08
EP0484340A4 (en) 1993-02-17
WO1991001997A1 (en) 1991-02-21
DE69024053D1 (de) 1996-01-18
EP0484340A1 (en) 1992-05-13

Similar Documents

Publication Publication Date Title
DK0484340T3 (da) Behandling til nedsættelse af ødem ved hjerne- og muskelbeskadigelser
Sistrunk Contribution to plastic surgery: Removal of scars by stages; an open operation for extensive laceration of the anal sphincter; the Kondoleon operation for elephantiasis
DE69030880D1 (de) Zusammensetzung zur Stimulierung des Immunsystems
DE60115433T2 (de) Verfahren zur behandlung von chronischen geschwüren
DE59600683D1 (de) Verwendung von Trospiumchlorid zur Herstellung eines Arzneimittels zur Behandlung von Blasenkrankheiten
ATE135914T1 (de) Aica riboside zur prophylaktischen behandlung von krankheiten mit einer verminderten durchblutung.
Coupland et al. Amputation for war wounds
Hartzell The use of living fascia transplant to repair a hernia of the tibialis anticus muscle
CN108420933A (zh) 一种治疗水火烧伤的组合物及其制备方法
RU2297217C2 (ru) Способ оптимизации репаративной регенерации кости
DE69431430T2 (de) Faktor XIII zur Behandlung von Hautwunden
SU1725840A1 (ru) Способ хирургического лечени паховых грыж
Ross et al. Treatment of 100 war wounds and burns
SU1119676A1 (ru) Способ обезболивани при повреждени х костей таза
Bodenham The problem of fractures with associated burn injuries: principles of treatment
WARTHEN JR The treatment of burns complicated by fractures of the extremities
ATE207353T1 (de) Verwendung von benzydamin zur behandlung von krankheitszuständen, die durch tnf verursacht werden
RU2281089C2 (ru) Способ лечения открытого перелома конечности
SU1491507A1 (ru) Способ подготовки к протезированию больных с культ ми нижних конечностей
SU1711896A1 (ru) Способ лечени длительно незаживающих ран
SU1113093A1 (ru) Способ лечени остеомиелита
RU2033824C1 (ru) Способ лечения трофических нарушений нижних конечностей при хронической венозной недостаточности
Mohs Chemosurgical amputation for gangrene
RU2327447C1 (ru) Способ лечения открытого перелома конечности
RU2123852C1 (ru) Способ лечения трофических язв